37651 |
Oncology; Immunology |
Clinical advantage of targeted sequencing for unbiased tumor mutationa... |
J IMMUNOTHER CANCER 2020 10.1136/jitc-2020-001199 |
박세훈A |
2020 |
37650 |
Medicine, General & Internal |
Asian variant of intravascular large B-cell lymphoma a comparison of c... |
KOREAN JOURNAL OF INTERNAL MEDICINE 2020 10.3904/kjim.2018.396 |
윤상은 |
2020 |
37649 |
Oncology |
Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Out... |
CANCERS 2020 10.3390/cancers12123548 |
윤상은 |
2020 |
37648 |
Multidisciplinary Sciences |
Prognostic significance of interim PET/CT response for the treatment o... |
SCI REP-UK 2020 10.1038/s41598-020-68310-w |
윤상은 |
2020 |
37647 |
Hematology |
Prediction and prevention of central nervous system relapse in patient... |
BLOOD 2020 10.1182/blood.2020005026 |
윤상은 |
2020 |
37646 |
Oncology |
Endothelial activation and stress index (EASIX) is a reliable predicto... |
BMC CANCER 2020 10.1186/s12885-020-07317-y |
윤상은 |
2020 |
37645 |
Hematology |
A risk model for relapsed/refractory aggressive NHL integrating clinic... |
BLOOD ADV 2020 10.1182/bloodadvances.2020002814 |
윤상은 |
2020 |
37644 |
Biophysics; Oncology; Hematology; Immunology; Transplantation |
Open-label, single arm, multicenter phase II study of VIDL induction c... |
BONE MARROW TRANSPL 2020 10.1038/s41409-020-01160-2 |
김원석 |
2020 |
37643 |
Hematology |
Prediction and prevention of central nervous system relapse in patient... |
BLOOD 2020 10.1182/blood.2020005026 |
김원석 |
2020 |
37642 |
Oncology |
First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma ... |
CANCERS 2020 10.3390/cancers12082192 |
김원석 |
2020 |